Cargando…

Telomere integrated scoring system of myelodysplastic syndrome

INTRODUCTION: Recently, multigene target sequencing is widely performed for the purpose of prognostic prediction and application of targeted therapy. Here, we proposed a new scoring system that encompasses gene variations, telomere length, and Revised International Prognostic Scoring System (IPSS‐R)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Hee Sue, Im, Kyongok, Shin, Dong‐Yeop, Yoon, Sung‐Soo, Kwon, Sunghoon, Kim, Suhng Wook, Lee, Dong Soon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978071/ https://www.ncbi.nlm.nih.gov/pubmed/36658792 http://dx.doi.org/10.1002/jcla.24839

Ejemplares similares

The importance of critically short telomere in myelodysplastic syndrome
por: Shin, Dong-Yeop, et al.
Publicado: (2022)

Dysregulation of Telomere Lengths and Telomerase Activity in Myelodysplastic Syndrome
por: Park, Hee Sue, et al.
Publicado: (2017)

Short telomere length and its correlation with gene mutations in myelodysplastic syndrome
por: Hwang, Sang Mee, et al.
Publicado: (2016)

Mutation of ten-eleven translocation-2 is associated with increased risk of autoimmune disease in patients with myelodysplastic syndrome
por: Oh, Yoon-Jeong, et al.
Publicado: (2020)

Increased Apoptotic Activity in Low-Risk Myelodysplastic Syndrome
por: Park, Songyi, et al.
Publicado: (2022)

Telomere length and its correlation with gene mutations in chronic lymphocytic leukemia in a Korean population
por: Song, Da Young, et al.
Publicado: (2019)

Differential impact of anti-thymocyte globulin dosing by disease risk index in alternative donor peripheral blood stem cell transplantation in patients with acute leukemia or myelodysplastic syndrome after reduced intensity conditioning
por: Choi, Mihong, et al.
Publicado: (2019)

Gene Expression Profiles Identify Biomarkers of Resistance to Decitabine in Myelodysplastic Syndromes
por: Kim, Seungyoun, et al.
Publicado: (2021)

MYD88 L265P Mutations Are Correlated with 6q Deletion in Korean Patients with Waldenström Macroglobulinemia
por: Kim, Jung-Ah, et al.
Publicado: (2014)

Similar transplant outcomes between haploidentical and unrelated donors after reduced-intensity conditioning with busulfan, fludarabine, and anti-thymocyte globulin in patients with acute leukemia or myelodysplastic syndrome
por: Choi, Mihong, et al.
Publicado: (2020)

Topotecan-Based Combination Chemotherapy in Patients with Transformed Chronic Myelogenous Leukemia and Advanced Myelodysplastic Syndrome
por: Park, Soo Jeong, et al.
Publicado: (2000)

Differential effects of donor lymphocyte infusion upon treatment response and GVHD according to relapse level and donor sources in patients with myelodysplastic syndrome
por: Park, Silvia, et al.
Publicado: (2021)

WHIM Syndrome With a Novel CXCR4 Variant in a Korean Child
por: Shin, Dong Woo, et al.
Publicado: (2017)

Pulmonary Leukocytoclastic Vasculitis as an Initial Presentation of Myelodysplastic Syndrome
por: Lee, Seung Hyun, et al.
Publicado: (2016)

Idiopathic hypereosinophilia is clonal disorder? Clonality identified by targeted sequencing
por: Lee, Jee-Soo, et al.
Publicado: (2017)

Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome
por: Suh, Koung Jin, et al.
Publicado: (2016)

Cryptic e1a2 BCR-ABL1 Fusion With Complex Chromosomal Abnormality in de novo Myelodysplastic Syndrome
por: Seo, Bo-Young, et al.
Publicado: (2015)

Comparison of Myelodysplastic Syndrome Prognostic Scoring Systems
por: Bektaş, Özlen, et al.
Publicado: (2016)

Genomic Profile of Chronic Lymphocytic Leukemia in Korea Identified by Targeted Sequencing
por: Kim, Jung-Ah, et al.
Publicado: (2016)

JAK2 V617F mutation in myelodysplastic syndrome, myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable, refractory anemia with ring sideroblasts with thrombocytosis, and acute myeloid leukemia
por: Jekarl, Dong Wook, et al.
Publicado: (2010)

A Case of Erythema Nodosum and Serositis Associated with Myelodysplastic Syndrome
por: Choi, Jung-Hye, et al.
Publicado: (2005)

No benefit of hypomethylating agents compared to supportive care for higher risk myelodysplastic syndrome
por: Sohn, Sang Kyun, et al.
Publicado: (2018)

3D Telomere Structure Analysis to Detect Genomic Instability and Cytogenetic Evolution in Myelodysplastic Syndromes
por: Rangel-Pozzo, Aline, et al.
Publicado: (2019)

Myelodysplastic syndromes and overlap syndromes
por: Chang, Yoon Hwan
Publicado: (2021)

Increased Expression of Interferon Signaling Genes in the Bone Marrow Microenvironment of Myelodysplastic Syndromes
por: Kim, Miyoung, et al.
Publicado: (2015)

Neutrophilic Dermatosis of the Palms in Association with Myelodysplastic Syndrome
por: Yang, Min-Young, et al.
Publicado: (2017)

A Case of Granulocytic Sarcoma of the Brain in a Patient with Myelodysplastic Syndrome
por: Lee, Ho Soo, et al.
Publicado: (1995)

The Implication of Cytogenetic Alterations in Pancreatic Ductal Adenocarcinoma and Intraductal Papillary Mucinous Neoplasm Identified by Fluorescence In Situ Hybridization and Their Potential Diagnostic Utility
por: Lim, Chang-Sup, et al.
Publicado: (2020)

Myelodysplastic syndrome: validation of flow cytometry multilineage score system
por: de Araújo, Helena Varela, et al.
Publicado: (2020)

The Hematologic Response to Anti-apoptotic Cytokine Therapy: Results of Pentoxifylline, Ciprofloxacin, and Dexamethasone Treatment for Patients with Myelodysplastic Syndrome
por: Kim, Min-Kyoung, et al.
Publicado: (2006)

Significance of TERT Genetic Alterations and Telomere Length in Hepatocellular Carcinoma
por: Jang, Jeong-Won, et al.
Publicado: (2021)

The prognostic impact of mutations in spliceosomal genes for myelodysplastic syndrome patients without ring sideroblasts
por: Kang, Min-Gu, et al.
Publicado: (2015)

Certain Autoimmune Manifestations Are Associated With Distinctive Karyotypes and Outcomes in Patients With Myelodysplastic Syndrome: A Retrospective Cohort Study
por: Lee, Sang Jin, et al.
Publicado: (2016)

Enhanced polo-like kinase 1 expression in myelodysplastic syndromes
por: Min, Kyoung Il, et al.
Publicado: (2019)

PB2011: TRANSFUSION BURDEN IS AN IMPORTANT PROGNOSTIC FACTOR IN LOWER-RISK MYELODYSPLASTIC SYNDROME
por: Lee, Jungmin, et al.
Publicado: (2023)

Better treatment outcomes in patients with actively treated therapy-related myeloid neoplasms harboring a normal karyotype
por: Kim, Sang-A, et al.
Publicado: (2018)

Prognosis in Myelodysplastic Syndromes: The Clinical Challenge of Genomic Integration
por: Chen-Liang, Tzu-Hua
Publicado: (2021)

Abnormal Ferroptosis in Myelodysplastic Syndrome
por: Lv, Qi, et al.
Publicado: (2020)

Model-based adaptive phase I trial design of post-transplant decitabine maintenance in myelodysplastic syndrome
por: Han, Seunghoon, et al.
Publicado: (2015)

Prognostic value of the controlling nutritional status score in patients with myelodysplastic syndromes
por: Chen, Qiuni, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k79aedhagv3t7k07e4jd0e0apj